Thompson Siegel & Walmsley LLC Catalent, Inc. Transaction History

Thompson Siegel & Walmsley LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$42.56 - $59.82 $7.13 Million - $10 Million	-167,439 Reduced 18.12%	756,866 $42.7 Million
Q4 2023 Feb 07, 2024	BUY	$32.18 - $46.57 $7.08 Million - $10.2 Million	219,983 Added 31.23%	924,305 $41.5 Million
Q3 2023 Nov 08, 2023	BUY	$44.2 - $50.2 $9.9 Million - $11.2 Million	223,944 Added 46.62%	704,322 $32.1 Million
Q2 2023 Aug 10, 2023	BUY	$31.86 - $67.26 $15.3 Million - $32.3 Million	480,378 New	480,378 $20.8 Million

216

73.2M

477K

2.02M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.